Vaskuläre und parenchymatöse Nierenkrankheiten
Author:
Tepel M.,Zidek W.
Reference57 articles.
1. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, for the DASH Collaborative Research Group (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117–1124
2. Bachmann J, Tepel M, Raidt H, Riezler R, Graefe U, Langer K, Zidek W (1995) Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 6:121–125
3. Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147–152
4. Bellomo R, Atkins RC (1993) Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron 63:249–254
5. Bennett-Richards K, Kattenhorn M, Donald A, Oakley G, Varghese Z, Rees L, Deanfield JE (2002) Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105:1810–1815